Protocol for a phase 2, partially blinded, randomized trial assessing the safety and efficacy of sorfequiline or bedaquiline in combination with pretomanid and linezolid in adult participants with newly diagnosed, drug-sensitive, smear-positive pulmonary tuberculosis (NC-009)
一项评估索非喹啉或贝达喹啉联合普瑞托马尼和利奈唑胺治疗新诊断的、药物敏感的、涂片阳性肺结核成年患者的安全性和有效性的 2 期、部分盲法、随机试验方案 (NC-009)
期刊:Trials
影响因子:2
doi:10.1186/s13063-025-09413-5
Olugbosi, M; Beumont, M; Lombard, L; Nedelman, J; Timm, J; Black, T; Bruning-Barry, R; Hickman, D; Lombardi, A; Betteridge, M; Egizi, E; Marcopulos, L; Henderson, J; Seidel, S; Foraida, S; Benhayoun, M; Sun, E
